K
LIVE

Serial Number

97132237

Owner

PURDUE PHARMA L.P.

Attorney

Fara S. Sunderji

Filing Date

Nov 18, 2021

Add to watchlist:

No watchlists yet
View on USPTO

K Trademark

Serial Number: 97132237

K is a trademark filed by PURDUE PHARMA L.P. on November 18, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

PURDUE PHARMA L.P. (284 trademarks)

STAMFORD, CT 06901

Entity Type: 13

Trademark Details

Filing Date

November 18, 2021

Registration Date

Not Registered

Published for Opposition

May 2, 2023

Goods & Services

A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose, opioid reversal, opioid use disorders, interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive Bladder (OAB), Alcohol Use Disorder, Substance Use Disorder, sleep disorders including Insomnia Associated with Alcohol Cessation (IAAC), anaphylaxis; pharmaceuticals for use in the treatment of oncology conditions, specifically glioblastoma multiforme (GBM), non Hodgkin lymphoma, solid tumors, melanoma, chronic myelogenous leukemia, hemato-oncology, refractory/relapsed malignancies, alone or in combination with other agents; analgesics; pharmaceuticals, namely, opioid antagonists; syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; syringes filled with opioid antagonists; injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectors filled with opioid antagonists; injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectable pharmaceuticals, namely, opioid antagonists

Pharmaceutical research and development

Filing History

SOU TEAS EXTENSION RECEIVED
Dec 1, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 26, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jun 25, 2025 EX4G
SOU EXTENSION 4 FILED
Jun 25, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 25, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 13, 2024 EX3G
SOU EXTENSION 3 FILED
Dec 13, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 13, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 25, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jun 25, 2024 EX2G
SOU EXTENSION 2 FILED
Jun 25, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 25, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 21, 2023 EXRA
SOU EXTENSION 1 GRANTED
Dec 19, 2023 EX1G
SOU EXTENSION 1 FILED
Dec 19, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 19, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 27, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 2, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 2, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 12, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 27, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 16, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 16, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 16, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 16, 2023 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 7, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 27, 2022 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 14, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 7, 2022 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jun 14, 2022 GPRN
PRIORITY ACTION E-MAILED
Jun 14, 2022 GPRA
PRIORITY ACTION WRITTEN
Jun 14, 2022 CPRA
ASSIGNED TO EXAMINER
Jun 7, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 24, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 23, 2021 NWOS
NEW APPLICATION ENTERED
Nov 22, 2021 NWAP